SCHEMBL15085696

SCHEMBL15085696

COc1ccc(C[C@@H](N)C(=O)O)c(Cl)c1OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNF P01375 1/20 0.43
KDM1A O60341 1/20 0.41
MAOB P27338 1/20 0.41
LDHA P00338 1/20 0.40
TPH1 P17752 2/20 0.40
KDM4E B2RXH2 3/20 0.40
MAPT P10636 3/20 0.40
MEN1 O00255 2/20 0.40
LMNA P02545 2/20 0.40
BLM P54132 2/20 0.40
PMP22 Q01453 2/20 0.40
KMT2A Q03164 2/20 0.40
HIF1A Q16665 2/20 0.40
NOS3 P29474 1/20 0.40
NOS1 P29475 1/20 0.40
NOS2 P35228 1/20 0.40
MPO P05164 1/20 0.40
TSHR P16473 1/20 0.40
USP2 O75604 2/20 0.40
PKM P14618 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31070923 1.00 TNF (0.43) TNFKDM1AMAOBLDHATPH1
SCHEMBL30036400 0.87 ALDH1A1 (0.46) KDM1AMAOBKDM4EMEN1KMT2A
SCHEMBL15105461 0.87 ALDH1A1 (0.46) KDM1AMAOBKDM4EMEN1KMT2A
SCHEMBL23387526 0.87 ALDH1A1 (0.46) KDM1AMAOBKDM4EMEN1KMT2A
SCHEMBL2675348 0.87 KDM4E (0.48) LDHATPH1KDM4EMAPTMEN1
SCHEMBL2675352 0.87 KDM4E (0.48) LDHATPH1KDM4EMAPTMEN1
SCHEMBL15085672 0.86 TNF (0.43) TNFLDHATPH1KDM4EMAPT
SCHEMBL21625554 0.86 TNF (0.43) TNFLDHATPH1KDM4EMAPT
SCHEMBL28719998 0.83 NOS3 (0.42) TPH1KDM4EMAPTMEN1LMNA
SCHEMBL15105463 0.81 KDM4E (0.43) KDM1AMAOBLDHAKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 231 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11931329-B2 Compositions and methods for treating anxiety-related disorders YAMO PHARMACEUTICALS LLC (US) 2024-03-19 US claimed
US-20240024268-A1 Methods for Dopamine Modulation in Human Neurologic Diseases SACKNER BERNSTEIN JONATHAN (US) 2024-01-25 US claimed
US-20240016815-A1 COMPOSITIONS AND METHODS FOR MODULATING CANCER IN NON-HUMAN MAMMALS HOFFMAN TECHNOLOGIES LLC 2024-01-18 US claimed
US-11806326-B2 Methods for dopamine modulation in human neurologic diseases SACKNER BERNSTEIN JONATHAN (US) 2023-11-07 US claimed
US-11786496-B2 Composition and methods for treating intestinal hyperpermeability YAMO PHARMACEUTICALS LLC (US) 2023-10-17 US claimed
US-20230141609-A1 Methods of Treating Amyotrophic Lateral Sclerosis and Symptoms YAMO PHARMACEUTICALS LLC (US) 2023-05-11 US claimed
US-20230040681-A1 COMPOSITIONS AND METHODS FOR TREATING ANXIETY-RELATED DISORDERS YAMO PHARMACEUTICALS LLC (US) 2023-02-09 US claimed
US-11534420-B2 Compositions and methods for treating cancer TYME, INC. (US) 2022-12-27 US claimed
CN-115515575-A Tyrosine derivatives for the modulation of cancer 迪美公司 2022-12-23 CN claimed
CN-114901272-A Sustained release preparation 霍夫曼技术有限责任公司 2022-08-12 CN claimed
WO-2015061288-A1 TYROSINE DERIVATIVES AND COMPOSITIONS COMPRISING THEM TYME, INC. (US) 2015-04-30 WO claimed
WO-2015061256-A1 HIGH-SPEED CENTRIFUGAL MIXING DEVICES AND METHODS OF USE TYME, INC. (US) 2015-04-30 WO claimed
US-20150112116-A1 TYROSINE DERIVATIVES AND COMPOSITIONS COMPRISING THEM OXFORD FINANCE LLC, AS COLLATERAL AGENT 2015-04-23 US claimed
US-20150111878-A1 COMPOSITIONS AND METHODS FOR TREATING INTESTINAL HYPERPERMEABILITY HOFFMAN STEVEN (US) 2015-04-23 US claimed
US-20150110735-A1 HIGH-SPEED CENTRIFUGAL MIXING DEVICES AND METHODS OF USE OXFORD FINANCE LLC, AS COLLATERAL AGENT 2015-04-23 US claimed
US-20150111937-A1 Compositions and Methods for Treating Intestinal Hyperpermeability YAMO PHARMACEUTICALS LLC 2015-04-23 US claimed
EP-2804599-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS Tyme, Inc. (US) 2014-11-26 EP claimed
WO-2013109610-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS HOFFMAN STEVEN (US) 2013-07-25 WO claimed
US-20130184214-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS OXFORD FINANCE LLC, AS COLLATERAL AGENT 2013-07-18 US claimed
US-8481498-B1 Pharmaceutical compositions and methods OXFORD FINANCE LLC, AS COLLATERAL AGENT 2013-07-09 US claimed